DNDN

Dendreon Corporation News Headlines

$1.13
*  
0.01
0.88%
Get DNDN Alerts
*Delayed - data as of Oct. 20, 2014  -  Find a broker to begin trading DNDN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Dendreon: Time To Answer Questions
10/13/2014 1:23:00 PM - Seeking Alpha


Griffin Securities' Keith Markey On The Promise Of RNAi And Synthetic Biologics
10/10/2014 8:54:00 AM - Seeking Alpha


A Lesson Learned: The Unfortunate Case Of GT Advanced Technologies
10/8/2014 7:50:00 AM - Seeking Alpha


The 1 Biotech Stock I'm Definitely Not Buying
10/7/2014 8:35:04 AM - Motley Fool


Cheap Stocks Wall Street Loves: Medivation
10/6/2014 11:11:02 AM - Motley Fool


Why Northwest Biotherapeutics Inc. Stock Skyrocketed 36% in 2014
9/26/2014 10:10:28 AM - Motley Fool


Following Biotech Stocks After Price Declines Of Greater Than 50%
9/25/2014 4:03:00 PM - Seeking Alpha


Dendreon Short Interest Hits Critical Point
9/25/2014 8:34:00 AM - Seeking Alpha


Dendreon (DNDN) in Focus: Stock Up 9.4% - Tale of the Tape
9/16/2014 8:44:00 AM - Zacks.com


Tokai Pharmaceuticals IPO: Lack Of Product Diversity Should Leave Investors Cautious
9/15/2014 8:41:00 AM - Seeking Alpha


Why Inovio Pharmaceuticals Inc. Plunged By 10% in 2014
9/12/2014 10:10:08 AM - Motley Fool


Medivation Eyes Blockbuster As Cancer Drug Gets An OK
9/11/2014 5:41:00 PM - Investor's Business Daily


Medivation Inc's FDA Approval Could be the Deathblow for Johnson & Johnson's Blockbuster Prostate Ca
9/10/2014 9:42:22 PM - Motley Fool


MannKind Corp. And The Folly Of Cult Biotech Stocks
8/18/2014 8:51:00 AM - Seeking Alpha


Ebola Vaccine and Inhaled Insulin Incoming
8/16/2014 6:01:02 AM - Motley Fool


Dendreon: Is The End Near?
8/13/2014 3:03:00 PM - Seeking Alpha


Dendreon Down on Default Risk, Reports Narrower Q2 Loss - Analyst Blog
8/13/2014 2:37:00 PM - Zacks.com


Sector Update: Health Care Stocks Trimming Earlier Losses Late; Dendreon Plunges on Convertible Note Risks
8/12/2014 3:53:07 PM - MT Newswires


Sector Update: Health Care
8/12/2014 3:51:17 PM - MT Newswires


Why Dendreon Corporation Stock Slumped Today
8/12/2014 10:46:51 AM - Motley Fool


Cel-Sci Is A Leader In The I-O Class Of Cancer Therapies
8/12/2014 10:43:00 AM - Seeking Alpha


Dendreon Provides A Major Warning To Shareholders
8/12/2014 9:30:00 AM - Seeking Alpha


One Drug To Rule Them All: Medivation's Xtandi To Dominate Prostate Cancer Market
8/5/2014 9:33:00 AM - Seeking Alpha


One Drug To Rule Them All: Medivation's Xtandi To Dominate Prostate Cancer Market
8/5/2014 8:51:23 AM - SeekingAlpha


3 Convincing Reasons To Buy Dendreon
7/24/2014 1:49:00 PM - Seeking Alpha